Skip to content

The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05924919
Enrollment
10
Registered
2023-06-29
Start date
2023-09-18
Completion date
2024-03-19
Last updated
2024-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Brief summary

The objective of this proposal is to investigate the acute effects of whole-body passive heat therapy using far-infrared technology on vascular function, exercise capacity, and renal function in CKD patients. The central hypothesis is that an acute bout of whole-body passive heat therapy will be well-tolerated and lead to acute improvements in large blood vessel (macrovascular) function, small blood vessel (microvascular) function, and exercise capacity without significantly altering markers of acute kidney injury.

Interventions

PROCEDUREWhole-body Passive Heat Therapy (HT)

The whole-body passive heat therapy (HT) intervention will consist of an acute bout of infrared sauna for 25 minutes at 60°C. Participants will lie supine on a memory foam pad.

PROCEDUREThermoneutral Control (CON)

Participants will remain in a room temperature environment (22°C) underneath the infrared domes for 25 minutes.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for participants with CKD: * Age \> 18 years old * Stage 2-4 CKD

Exclusion criteria

for participants with CKD: * Unstable medical conditions characterized by frequent or unpredictable biological, chemical, or psychological changes * Uncontrolled hypertension * Current fluid restrictions * End stage kidney disease or currently on dialysis treatment * Body weight \< 40kg * Exhibits any contraindications to exercise as per ACSM guidelines * Regular tobacco and/or nicotine use * History of heat-related illness * Participates in regular exercise and/or sauna use * Current hormone replacement therapy * Pacemaker or electro-medical implant * Persons with or at risk of intestinal disorders including gastroporesis * History of diverticula * Persons who have undergone surgical procedures in the GI tract * Swallowing disorders * Chron's disease * Current pregnancy * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Renal Safety of Heat TherapyChange from baseline to 90 minutes after interventionChange in urinary NGAL
Tolerability of Heat Therapy as Assessed using Validated Questionnaires of Thermal PerceptionDuring 25 minute interventionSelf reported perception of heat using the the Thermal Sensation Scale.

Secondary

MeasureTime frameDescription
Conduit artery endothelial function90 minutes after interventionBrachial artery flow-mediated dilation assessed by high-resolution duplex ultrasound.
Lower Limb Microvascular Function90 minutes after interventionLower limb microvascular function will be assessed with high-resolution duplex ultrasound during passive leg movement (PLM) technique.
Exercise Capacity90 minutes after interventionThe 6-minute walk test distance.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026